| Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities DT Jamison, A Alwan, CN Mock, R Nugent, D Watkins, O Adeyi, S Anand, ... The Lancet 391 (10125), 1108-1120, 2018 | 211 | 2018 |
| The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis S Verguet, CL Gauvreau, S Mishra, M MacLennan, SM Murphy, ... The Lancet Global Health 3 (4), e206-e216, 2015 | 168 | 2015 |
| Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities D Prabhakaran, S Anand, D Watkins, T Gaziano, Y Wu, JC Mbanya, ... The Lancet 391 (10126), 1224-1236, 2018 | 164 | 2018 |
| Provider costs for prevention and treatment of cardiovascular and related conditions in low-and middle-income countries: a systematic review ED Brouwer, D Watkins, Z Olson, J Goett, R Nugent, C Levin BMC Public Health 15, 1-17, 2015 | 80 | 2015 |
| Cost-effectiveness of drugs to treat relapsed/refractory multiple myeloma in the United States JJ Carlson, GF Guzauskas, RH Chapman, PG Synnott, S Liu, ET Russo, ... Journal of managed care & specialty pharmacy 24 (1), 29-38, 2018 | 57 | 2018 |
| The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon N Salti, E Brouwer, S Verguet Social Science & Medicine 170, 161-169, 2016 | 52 | 2016 |
| Disease-modifying therapies for relapsing–remitting and primary progressive multiple sclerosis: a cost-utility analysis M Zimmermann, E Brouwer, JA Tice, M Seidner, AM Loos, S Liu, ... CNS drugs 32, 1145-1157, 2018 | 50 | 2018 |
| Benefits and costs of the non-communicable disease targets for the post-2015 development agenda R Nugent, E Brouwer Copenhagen Consensus Center., 2015 | 36 | 2015 |
| Minimum threshold of bariatric surgical weight loss for initial diabetes remission D Barthold, E Brouwer, LJ Barton, DE Arterburn, A Basu, A Courcoulas, ... Diabetes Care 45 (1), 92-99, 2022 | 32 | 2022 |
| Alternative approaches to quality-adjusted life-year estimation within standard cost-effectiveness models: literature review, feasibility assessment, and impact evaluation JJ Carlson, ED Brouwer, E Kim, P Wright, RB McQueen Value in Health 23 (12), 1523-1533, 2020 | 23 | 2020 |
| Gender patterns of tuberculosis testing and disease in South Africa ZM McLaren, E Brouwer, D Ederer, K Fischer, N Branson The International Journal of Tuberculosis and Lung Disease 19 (1), 104-110, 2015 | 20 | 2015 |
| Costs and cost-effectiveness of interventions and policies to prevent and treat cardiovascular and respiratory diseases TA Gaziano, M Suhrcke, E Brouwer, C Levin, I Nikolic, R Nugent Cardiovascular, Respiratory, and Related Disorders. 3rd edition, 2017 | 18 | 2017 |
| Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system E Brouwer, K Yeung, D Barthold, R Hansen Journal of Managed Care & Specialty Pharmacy 27 (6), 732-742, 2021 | 13 | 2021 |
| Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal L Di Giorgio, M Mvundura, J Tumusiime, A Namagembe, A Ba, ... Contraception 98 (5), 389-395, 2018 | 13 | 2018 |
| Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer FB Musa, E Brouwer, J Ting, NRM Schwartz, A Surinach, L Bloudek, ... Gynecologic oncology 164 (3), 645-650, 2022 | 12 | 2022 |
| A cost-benefit analysis of a National Hypertension Treatment Program in Bangladesh R Nugent, E Brower, A Cravioto, T Koehlmoos Preventive medicine 105, S56-S61, 2017 | 12 | 2017 |
| The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis. Lancet Glob Health 2015; 3 (4 … S Verguet, CL Gauvreau, S Mishra, M MacLennan, SM Murphy, ... | 12 | |
| Costs and affordability of essential universal health coverage in low-and middle-income countries D Watkins, J Qi, S Horton, E Brouwer Disease Control Priorities, 2017 | 11 | 2017 |
| La costo-efectividad de las intervenciones y políticas para el control de las enfermedades no transmisibles y sus factores de riesgo en América Latina y el Caribe: revisión … D Watkin, R Poggio, FA Augustovski, E Brouwer, A Pichon Riviere, ... Organización Panamericana de la Salud, 2017 | 11 | 2017 |
| Economic benefit-cost analysis of select secondary prevention interventions in LMIC R Nugent, E Brouwer Global Heart 10 (4), 319-321, 2015 | 11 | 2015 |
